As the global industry association for generics and biosimilars companies, the International Generic and Biosimilar medicines Association (IGBA) is perfectly positioned to take an international view of the intellectual property landscape.
Recently, IGBA chair Jim Keon – who is also president of the Canadian Generic Pharmaceutical Association (CGPA) – and newly-appointed secretary general Suzette Kox (Also see "Kox Named As...